Article
NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer
2019-08-27
Abstract excerpt
<title>Abstract</title> <p>Background NRF2 overexpression confers poor prognosis in some cancers but its prognostic role in colorectal cancer (CRC) is unknown. As a transcription factor, we hypothesise a signature of NRF2 regulated genes could act as a prognostic biomarker in CRC and reveal novel biological insights.Methods Using known NRF2 regulated genes, differentially expressed in CRC, we defined a signature...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d8bc883a-53c9-5d26-b08a-e24441bcd9b9
- DOI
- 10.21203/rs.2.13614/v1
